110 Oncology journals listed in the Directory of Open Access Journals with at least 10 papers in 2025. DOAJ is an independent, openly published list of open-access journals that meet its criteria.
As of 2 October 2026. From OpenAlex, Crossref and DOAJ. ORBIT Tier is our own ranking within a field, not a Scopus or Web of Science quartile.
| Journal | ISSN | Papers in 2025 | ORBIT Tier | Fee to publish | Open access | DOAJ | Country |
|---|---|---|---|---|---|---|---|
| Frontiers in Oncology | 2234-943X | 4,580 | 1 | ≈ ₹3,63,273 to publish | Yes | Yes | Switzerland |
| BMC Cancer | 1471-2407 | 2,104 | 1 | ≈ ₹3,42,821 to publish | Yes | Yes | United Kingdom |
| ESMO Open | 2059-7029 | 1,641 | 1 | ≈ ₹4,15,176 to publish | Yes | Yes | Netherlands |
| Journal of Translational Medicine | 1479-5876 | 1,581 | 1 | ≈ ₹3,64,587 to publish | Yes | Yes | United Kingdom |
| Journal of Inflammation Research | 1178-7031 | 1,172 | 1 | ≈ ₹4,16,139 to publish | Yes | Yes | New Zealand |
| Cancer Medicine | 2045-7634 | 1,016 | 1 | ≈ ₹4,78,753 to publish | Yes | Yes | United Kingdom |
| Current Oncology | 1198-0052 | 711 | 1 | ≈ ₹2,53,715 to publish | Yes | Yes | Canada |
| Journal for ImmunoTherapy of Cancer | 2051-1426 | 704 | 1 | ≈ ₹3,04,673 to publish | Yes | Yes | United Kingdom |
| The Oncologist | 1083-7159 | 575 | 1 | ≈ ₹3,53,333 to publish | Yes | Yes | United Kingdom |
| MedComm | 2688-2663 | 533 | 1 | ≈ ₹3,70,865 to publish | Yes | Yes | China |
| Asian Pacific Journal of Cancer Prevention | 1513-7368 | 532 | 1 | ≈ ₹38,531 to publish | Yes | Yes | Iran |
| EJC Skin Cancer | 2772-6118 | 494 | 3 | ≈ ₹1,12,704 to publish | Yes | Yes | |
| ESMO Real World Data and Digital Oncology | 2949-8201 | 460 | 2 | ≈ ₹3,35,223 to publish | Yes | Yes | |
| Cell Reports Medicine | 2666-3791 | 455 | 1 | ≈ ₹5,57,742 to publish | Yes | Yes | United States |
| Inorganics | 2304-6740 | 424 | 1 | ≈ ₹3,11,377 to publish | Yes | Yes | Switzerland |
| Clinical and Translational Medicine | 2001-1326 | 416 | 1 | ≈ ₹3,50,636 to publish | Yes | Yes | United States |
| Immuno-Oncology Technology | 2590-0188 | 407 | 2 | ≈ ₹3,36,187 to publish | Yes | Yes | United Kingdom |
| Translational Oncology | 1936-5233 | 378 | 1 | ≈ ₹3,73,755 to publish | Yes | Yes | United States |
| Cancer Reports | 2573-8348 | 354 | 1 | ≈ ₹3,31,370 to publish | Yes | Yes | United States |
| Journal of Cancer Research and Clinical Oncology | 0084-5353 | 327 | 1 | ≈ ₹3,58,057 to publish | Yes | Yes | Germany |
| Therapeutic Advances in Medical Oncology | 1758-8340 | 279 | 1 | ≈ ₹2,69,720 to publish | Yes | Yes | United Kingdom |
| JCO Global Oncology | 2687-8941 | 274 | 1 | ≈ ₹2,38,124 to publish | Yes | Yes | United States |
| Biological and Pharmaceutical Bulletin | 0918-6158 | 250 | 1 | ≈ ₹54,876 to publish | Yes | Yes | Japan |
| Cancer Control | 1073-2748 | 245 | 1 | ≈ ₹2,55,271 to publish | Yes | Yes | United States |
| ecancermedicalscience | 1754-6605 | 229 | 1 | ≈ ₹1,27,478 to publish | Yes | Yes | United Kingdom |
| Case Reports in Oncology | 1662-6575 | 222 | 2 | ≈ ₹1,16,478 to publish | Yes | Yes | Switzerland |
| Cellular and Molecular Gastroenterology and Hepatology | 2352-345X | 220 | 1 | ≈ ₹3,63,159 to publish | Yes | Yes | Netherlands |
| Biomolecules and Biomedicine | 2831-0896 | 214 | 1 | ≈ ₹1,30,054 to publish | Yes | Yes | Bosnia & Herzegovina |
| Cell Proliferation | 0960-7722 | 209 | 1 | ≈ ₹3,37,379 to publish | Yes | Yes | United Kingdom |
| Indian Journal of Medical and Paediatric Oncology | 0971-5851 | 205 | 3 | Free to publish — per DOAJ | Yes | Yes | India |
| Cancer Research Communications | 2767-9764 | 194 | 1 | ≈ ₹2,45,638 to publish | Yes | Yes | United States |
| Asia-Pacific Journal of Oncology Nursing | 2347-5625 | 193 | 1 | ≈ ₹2,38,895 to publish | Yes | Yes | India |
| Molecular Therapy Oncology | 2950-3299 | 167 | 1 | ≈ ₹3,75,681 to publish | Yes | Yes | |
| Biomarker Research | 2050-7771 | 166 | 1 | ≈ ₹3,47,174 to publish | Yes | Yes | United Kingdom |
| Journal of Patient-Reported Outcomes | 2509-8020 | 157 | 1 | ≈ ₹1,94,809 to publish | Yes | Yes | United Kingdom |
| JMIR Cancer | 2369-1999 | 151 | 1 | ≈ ₹1,91,212 to publish | Yes | Yes | Canada |
| Deutsches Ärzteblatt | 0012-1207 | 149 | 4 | Free to publish — per DOAJ | Yes | Yes | Germany |
| ESMO Gastrointestinal Oncology | 2949-8198 | 141 | 1 | ≈ ₹3,35,223 to publish | Yes | Yes | |
| Experimental Hematology and Oncology | 2162-3619 | 141 | 1 | ≈ ₹3,25,408 to publish | Yes | Yes | United Kingdom |
| Integrative Cancer Therapies | 1534-7354 | 124 | 1 | ≈ ₹2,55,271 to publish | Yes | Yes | United States |
| JNCI Cancer Spectrum | 2515-5091 | 123 | 1 | ≈ ₹1,87,937 to publish | Yes | Yes | United Kingdom |
| Cancer Biology and Medicine | 2095-3941 | 120 | 1 | ≈ ₹2,69,720 to publish | Yes | Yes | China |
| OncoImmunology | 2162-4011 | 120 | 1 | ≈ ₹3,17,884 to publish | Yes | Yes | United States |
| Cellular Oncology | 1570-5870 | 105 | 1 | ≈ ₹2,29,262 to publish | Yes | Yes | Netherlands |
| Oncology in Clinical Practice | 2450-1654 | 102 | 2 | Free to publish — per DOAJ | Yes | Yes | Poland |
| Journal of the Serbian Chemical Society | 0352-5139 | 98 | 2 | Free to publish — per DOAJ | Yes | Yes | Serbia |
| ImmunoTargets and Therapy | 2253-1556 | 89 | 1 | ≈ ₹4,16,139 to publish | Yes | Yes | New Zealand |
| JCO oncology advances. | 2994-9750 | 89 | 1 | ≈ ₹3,66,049 to publish | Yes | Yes | PAU |
| Cancer Biology & Therapy | 1538-4047 | 88 | 1 | ≈ ₹3,07,649 to publish | Yes | Yes | United States |
| Oncology and Therapy | 2366-1070 | 88 | 1 | ≈ ₹6,47,550 to publish | Yes | Yes | United Kingdom |
| BJC Reports | 2731-9377 | 85 | 1 | ≈ ₹2,49,225 to publish | Yes | Yes | |
| Acta chimica slovenica | 1318-0207 | 80 | 2 | Free to publish — per DOAJ | Yes | Yes | Slovenia |
| Holistic Integrative Oncology | 2731-4529 | 78 | 1 | Free to publish — per DOAJ | Yes | Yes | |
| Journal of bone oncology | 2212-1366 | 76 | 1 | ≈ ₹3,26,554 to publish | Yes | Yes | Netherlands |
| BMJ Oncology | 2752-7948 | 73 | 1 | ≈ ₹3,04,673 to publish | Yes | Yes | |
| Case Reports in Oncological Medicine | 2090-6706 | 73 | 2 | ≈ ₹83,806 to publish | Yes | Yes | United Kingdom |
| Exploration of Targeted Anti-tumor Therapy | 2692-3114 | 71 | 1 | ≈ ₹1,92,657 to publish | Yes | Yes | United States |
| Asian Pacific Journal of Cancer Biology | 2538-4635 | 69 | 1 | ≈ ₹28,899 to publish | Yes | Yes | Iran |
| Clinical Medicine Insights Oncology | 1179-5549 | 68 | 1 | ≈ ₹2,55,271 to publish | Yes | Yes | United Kingdom |
| Journal of the National Cancer Center | 2096-8663 | 68 | 1 | ≈ ₹2,60,087 to publish | Yes | Yes | China |
| Cancer Pathogenesis and Therapy | 2949-7132 | 67 | 1 | ≈ ₹2,60,087 to publish | Yes | Yes | |
| Asian Pacific Journal of Cancer Care | 2588-3682 | 66 | 2 | ≈ ₹28,899 to publish | Yes | Yes | Iran |
| Cancer Innovation | 2770-9183 | 59 | 1 | ≈ ₹2,60,087 to publish | Yes | Yes | |
| Cancer Research Statistics and Treatment | 2590-3225 | 59 | 2 | Free to publish — per DOAJ | Yes | Yes | India |
| Nowotwory Journal of Oncology | 0029-540X | 59 | 2 | Free to publish — per DOAJ | Yes | Yes | Poland |
| Academia oncology. | 2998-7741 | 58 | 2 | ≈ ₹1,92,657 to publish | Yes | Yes | CAU |
| Current Problems in Cancer Case Reports | 2666-6219 | 55 | 2 | ≈ ₹1,16,558 to publish | Yes | Yes | United States |
| Onco | 2673-7523 | 55 | 1 | ≈ ₹1,15,325 to publish | Yes | Yes | Switzerland |
| MedComm – Oncology | 2769-6448 | 51 | 1 | ≈ ₹2,50,454 to publish | Yes | Yes | |
| Oncology Reviews | 1970-5557 | 50 | 1 | ≈ ₹2,24,883 to publish | Yes | Yes | Switzerland |
| Lymphatics | 2813-3307 | 49 | 2 | ≈ ₹1,15,325 to publish | Yes | Yes | |
| Współczesna Onkologia | 1428-2526 | 48 | 2 | ≈ ₹41,059 to publish | Yes | Yes | Poland |
| Basic & Clinical Cancer Research | 2228-5466 | 46 | 3 | Free to publish — per DOAJ | Yes | Yes | Iran |
| Clinical Surgical Oncology | 2773-160X | 45 | 2 | ≈ ₹1,92,657 to publish | Yes | Yes | |
| Journal of Mind and Medical Sciences | 2392-7674 | 45 | 1 | ≈ ₹1,38,390 to publish | Yes | Yes | Romania |
| Oncology and Translational Medicine | 2095-9621 | 43 | 1 | Free to publish — per DOAJ | Yes | Yes | |
| Journal of Oncological Sciences | 2452-3364 | 42 | 2 | Free to publish — per DOAJ | Yes | Yes | Türkiye |
| Acta haematologica oncologica Turcica. | 3061-9947 | 40 | 3 | Free to publish — per DOAJ | Yes | Yes | TU |
| Gaceta Mexicana de Oncología | 1665-9201 | 40 | 3 | Free to publish — per DOAJ | Yes | Yes | Mexico |
| Precision Clinical Medicine | 2096-5303 | 40 | 1 | ≈ ₹1,92,657 to publish | Yes | Yes | United Kingdom |
| Journal of Pancreatology | 2096-5664 | 39 | 2 | Free to publish — per DOAJ | Yes | Yes | China |
| Polish Journal of Pathology | 1233-9687 | 38 | 2 | ≈ ₹41,356 to publish | Yes | Yes | Poland |
| Український радіологічний та онкологічний журнал | 1027-3204 | 38 | 2 | ≈ ₹10,883 to publish | Yes | Yes | Ukraine |
| Annals of Oncology Research and Therapy | 2772-8382 | 36 | 3 | Free to publish — per DOAJ | Yes | Yes | Netherlands |
| Journal of Psychosocial Oncology Research and Practice | 2637-5974 | 32 | 2 | ≈ ₹1,15,594 to publish | Yes | Yes | United States |
| Frontiers in Chemical Biology | 2813-530X | 31 | 1 | ≈ ₹2,24,883 to publish | Yes | Yes | |
| Journal of Immunotherapy and Precision Oncology | 2590-017X | 30 | 1 | ≈ ₹2,31,189 to publish | Yes | Yes | United States |
| South Russian Journal of Cancer | 2686-9039 | 30 | 2 | Free to publish — per DOAJ | Yes | Yes | Russia |
| Blood Immunology & Cellular Therapy | 3050-5976 | 29 | 2 | ≈ ₹2,88,986 to publish | Yes | Yes | |
| Colorectal Cancer | 1758-194X | 29 | 2 | ≈ ₹2,20,945 to publish | Yes | Yes | United Kingdom |
| Bioinorganic Chemistry and Applications | 1565-3633 | 27 | 1 | ≈ ₹1,72,428 to publish | Yes | Yes | Egypt |
| The International Journal of Biological Markers | 0393-6155 | 26 | 1 | ≈ ₹2,69,720 to publish | Yes | Yes | Italy |
| Egyptian Journal of Cancer and Biomedical Research. | 3009-6391 | 25 | 3 | ≈ ₹11,078 to publish | Yes | Yes | Ukraine |
| Oncología (Ecuador) | 1390-0110 | 25 | 4 | Free to publish — per DOAJ | Yes | Yes | Ecuador |
| Clinical Cancer Bulletin | 2791-3937 | 24 | 1 | Free to publish — per DOAJ | Yes | Yes | |
| Journal of Cancer Research and Practice | 2311-3006 | 24 | 2 | Free to publish — per DOAJ | Yes | Yes | Netherlands |
| South African Journal of Oncology | 2518-8704 | 22 | 2 | ≈ ₹59,850 to publish | Yes | Yes | South Africa |
| Journal of Pharmacy & Pharmaceutical Sciences | 1482-1826 | 21 | 1 | ≈ ₹2,11,923 to publish | Yes | Yes | Canada |
| Liaquat National Journal of Cancer Care | 2789-0112 | 21 | 4 | Free to publish — per DOAJ | Yes | Yes | Pakistan |
| Patient Related Outcome Measures | 1179-271X | 19 | 1 | ≈ ₹2,88,022 to publish | Yes | Yes | New Zealand |
The first 100 of 110 journals, by papers published in 2025. The rest load in the browser, with search, sort and filters.